Jesús
San Miguel Izquierdo
Consultor Investigador
University of North Carolina at Chapel Hill
Chapel Hill, Estados UnidosPublicacions en col·laboració amb investigadors/es de University of North Carolina at Chapel Hill (4)
2021
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Blood Cancer Journal, Vol. 11, Núm. 12
2008
-
Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Leukemia, Vol. 22, Núm. 2, pp. 414-423
2007
-
Randomized phase III study of pegylated liposomal doxorubicin plus bortezomib compared with bortezomib alone in relapsed or refractory multiple myeloma: Combination therapy improves time to progression
Journal of Clinical Oncology, Vol. 25, Núm. 25, pp. 3892-3901
2006
-
A practical update on the use of bortezomib in the management of multiple myeloma
Oncologist, Vol. 11, Núm. 1, pp. 51-61